Information Provided By:
Fly News Breaks for June 24, 2016
ALNY, NVAX
Jun 24, 2016 | 13:25 EDT
Piper Jaffray analyst Edward Tenthoff said Novavax (NVAX) and Alnylam (ALNY) each have little to no European exposure and recommends buying their stocks on the weakness caused across markets by U.K voting to exit the European Union. The analyst, who has Overweight ratings on both stocks, noted that Novavax has Phase III RSV vaccine data due in the third quarter and Alnylam has two clinical data read-outs due in July.
News For NVAX;ALNY From the Last 2 Days
There are no results for your query NVAX;ALNY